Informations générales (source: ClinicalTrials.gov)
Study on the Occurrence of Head and Neck Cancers During Pregnancy
Observational
Centre Francois Baclesse (Voir sur ClinicalTrials)
novembre 2018
mai 2027
29 août 2025
Head and neck cancers that occurred during pregnancy
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CLCC INSTITUT GUSTAVE ROUSSY | Ingrid BREUSKIN | 17/02/2024 12:26:19 | Contacter | ||
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| IFSI AP-HP DE L'HÔPITAL TENON | Contact (sur clinicalTrials) | ||||
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Centre François Baclesse - Caen - France | Contact (sur clinicalTrials) | ||||
| Chu Grenoble Alpes - Grenoble - France | Contact (sur clinicalTrials) | ||||
| Chu Poitiers - Poitiers - France | Contact (sur clinicalTrials) | ||||
| Chu Toulouse - Toulouse - France | Contact (sur clinicalTrials) | ||||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Chu Besancon - Besançon - France | Contact (sur clinicalTrials) | ||||
| Chu Bordeaux - Bordeaux - France | Contact (sur clinicalTrials) | ||||
Critères
Femme
Inclusion Criteria:
- 18 year old woman or over at the time of participation
- PS 0 -2
- Cancer diagnosed (biopsy date) from 01/01/2010 between the second week of pregnancy
and the 12 months postpartum.
- Primitive may concern the following sites:
oral cavity, nasopharynx, oropharynx, hypopharynx, larynx, prevalent lymphadenopathy,
nasal cavity, salivary glands, dental tumors, ear tumors, paragangliomas optic pathways,
facial sinus / facial mass, nose, ear and other head and neck
- All histologies (epithelial tumors, sarcomas, mucosal melanomas, embryonic tumors,
undifferentiated tumors)
- Patient receiving or having received a specific oncological treatment among surgery,
radiotherapy, chemotherapy, hormone therapy.
- All stages allowed: localized stages and metastatic stages immediately.
- No opposition of the patient to participate in this study
- 18 year old woman or over at the time of participation
- PS 0 -2
- Cancer diagnosed (biopsy date) from 01/01/2010 between the second week of pregnancy
and the 12 months postpartum.
- Primitive may concern the following sites:
oral cavity, nasopharynx, oropharynx, hypopharynx, larynx, prevalent lymphadenopathy,
nasal cavity, salivary glands, dental tumors, ear tumors, paragangliomas optic pathways,
facial sinus / facial mass, nose, ear and other head and neck
- All histologies (epithelial tumors, sarcomas, mucosal melanomas, embryonic tumors,
undifferentiated tumors)
- Patient receiving or having received a specific oncological treatment among surgery,
radiotherapy, chemotherapy, hormone therapy.
- All stages allowed: localized stages and metastatic stages immediately.
- No opposition of the patient to participate in this study
- Any other neoplastic antecedent
- Exclusion of metastases at the level of the VADS of another primitive than a cancer
of the VADS
- Exclusion of hematological tumors (lymphoma) and glial tumors
- Person subject to a legal protection measure or unable to express their consent